Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Cardiovascular disease in children with CKD or ESRD

Abstract

Cardiovascular disease accounts for 40% of all deaths among pediatric patients with end-stage renal disease (ESRD). ESRD has a particularly large influence on the cardiovascular system in children, as indicated by the more than 700-fold increased risk of cardiac death in affected individuals compared with healthy children of the same age. The prevalence of ESRD is low in children, however, and, consequently, few cardiac deaths occur. As a result, prospective follow-up studies of cardiac risk factors in the pediatric setting are lacking. Nevertheless, cross-sectional data on cardiac disease in children with ESRD have started to emerge. Arterial medial calcification is more prominent in children than classic atherosclerotic intimal calcification. Current data suggest that endothelial dysfunction appears early in renal failure in children, and is followed by arterial medial calcification. This calcification causes arterial wall stiffening and subsequently left ventricular hypertrophy. High systolic blood pressure and serum concentrations of intact parathyroid hormone, calcium and phosphate, as well as long-term dialysis, seem to be important risk factors for cardiovascular disease in pediatric patients with ESRD. These features are important targets for preventive intervention. This Review summarizes the currently available data on cardiovascular disease in children with renal failure.

Key Points

  • Children with chronic kidney disease or end-stage renal disease have an increased risk of cardiovascular death

  • Sudden cardiac death is the most common cause of cardiovascular death in children with renal failure

  • Arterial medial calcification (which increases arterial stiffness), left ventricular hypertrophy and endothelial dysfunction are prevalent in children with renal failure

  • Several modifiable factors predict cardiovascular abnormalities in children with chronic kidney disease or end-stage renal disease, including hyperphosphatemia, anemia, insufficient blood pressure control, high intake of calcium salts or active vitamin D and high serum levels of intact parathyroid hormone

  • Transplantation and intensified hemodialysis regimens can minimize several of the modifiable risk factors described above

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McDonald, S.P. & Craig, J. C. Long-term survival of children with end-stage renal disease. N. Engl. J. Med. 350, 2654–2662 (2004).

    Article  CAS  Google Scholar 

  2. Groothoff, J. W. et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 61, 621–629 (2002).

    Google Scholar 

  3. Chavers, B. M., Li, S., Collins, A. J. & Herzog, C. A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 62, 648–653 (2002).

    Google Scholar 

  4. Parekh, R. S., Carroll, C. E., Wolfe, R. A. & Port, F. K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141, 191–197 (2002).

    Article  CAS  Google Scholar 

  5. Kavey, R. E. et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114, 2710–2738 (2006).

    Article  Google Scholar 

  6. Mitsnefes, M. M. Cardiovascular disease in children with chronic kidney disease. Adv. Chronic Kidney Dis. 12, 397–405 (2005).

    Google Scholar 

  7. Oh, J. et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106, 100–105 (2002).

    Article  Google Scholar 

  8. Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32 (Suppl. 3), S112–S119 (2002).

    Google Scholar 

  9. Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).

    Article  CAS  Google Scholar 

  10. London, G. M. et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int. 65, 700–704 (2004).

    Article  Google Scholar 

  11. Zoccali, C. The endothelium as a target in renal diseases. J. Nephrol. 20 (Suppl. 12), S39–S44 (2002).

    Google Scholar 

  12. Johnson, R. C., Leopold, J. A. & Loscalzo, J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ. Res. 99, 1044–1059 (2006).

    Article  CAS  Google Scholar 

  13. Choi, J. H. et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol. 24, 1246–1252 (2004).

    Article  CAS  Google Scholar 

  14. Werner, N. et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999–1007 (2005).

    Article  CAS  Google Scholar 

  15. Jie, K. E., Goossens, M. H., van Oostrom, O., Lilien, M. R. & Verhaar, M. C. Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis 202, 345–347 (2009).

    Article  CAS  Google Scholar 

  16. Civilibal, M. et al. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr. Nephrol. 22, 1021–1029 (2007).

    Article  Google Scholar 

  17. Lilien, M. R. et al. Vascular function in children after renal transplantation. Am. J. Kidney Dis. 41, 684–691 (2003).

    Article  Google Scholar 

  18. Kari, J. A. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52, 468–472 (1997).

    Article  CAS  Google Scholar 

  19. Lilien, M. R., Koomans, H. A. & Schroder, C. H. Hemodialysis acutely impairs endothelial function in children. Pediatr. Nephrol. 20, 200–204 (2007).

    Article  Google Scholar 

  20. Wang, S. et al. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography–tandem mass spectrometry. Clin. Chem. Lab. Med. 45, 1305–1312 (2007).

    CAS  PubMed  Google Scholar 

  21. Hussein, G., Bughdady, Y., Kandil, M. E., Bazaraa, H. M. & Taher, H. Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr. Nephrol. 23, 2025–2030 (2008).

    Article  Google Scholar 

  22. Wilson, A. C. et al. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr. Nephrol. 23, 1297–1302 (2007).

    Article  Google Scholar 

  23. Lilien, M. R., Schroder, C. H., Levtchenko, E. N. & Koomans, H. A. Growth hormone therapy influences endothelial function in children with renal failure. Pediatr. Nephrol. 19, 785–789 (2004).

    Article  Google Scholar 

  24. London, G. M. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731–1740 (2003).

    Article  Google Scholar 

  25. Blacher, J. et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99, 2434–2439 (1999).

    Article  CAS  Google Scholar 

  26. Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z. & Curhan, G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627–2633 (2005).

    Article  CAS  Google Scholar 

  27. Giachelli, C. M. et al. Vascular calcification and inorganic phosphate. Am. J. Kidney Dis. 38 (Suppl. 1), S34–S37 (2001).

    Article  CAS  Google Scholar 

  28. Jono, S . et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87, E10–E17 (2000).

    Article  CAS  Google Scholar 

  29. London, G. M., Marchais, S. J., Guérin, A. P. & Métivier, F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr. Opin. Nephrol. Hypertens. 14, 525–531 (2005).

    Article  CAS  Google Scholar 

  30. Jourdan, C. et al. Normative values for intima–media thickness and distensibility of large arteries in healthy adolescents. J. Hypertens. 23, 1707–1715 (2007).

    Article  Google Scholar 

  31. Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M. & Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115, 459–467 (2007).

    Article  Google Scholar 

  32. Covic, A. et al. Increased arterial stiffness in children on haemodialysis. Nephrol. Dial. Transplant. 21, 729–735 (2006).

    Article  Google Scholar 

  33. Shroff, R. C. et al. Mineral metabolism and vascular damage in children on dialysis. J. Am. Soc. Nephrol. 18, 2996–3003 (2007).

    Article  CAS  Google Scholar 

  34. Groothoff, J. W. et al. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J. Am. Soc. Nephrol. 13, 2953–2961 (2002).

    Article  Google Scholar 

  35. Litwin, M. et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J. Am. Soc. Nephrol. 16, 1494–1500 (2005).

    Article  Google Scholar 

  36. Mitsnefes, M. M. et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J. Am. Soc. Nephrol. 16, 2796–2803 (2005).

    Article  CAS  Google Scholar 

  37. Litwin, M. et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol. Dial. Transplant. 23, 2552–2557 (2008).

    Article  Google Scholar 

  38. Goodman, W. G. et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342, 1478–1483 (2000).

    Article  CAS  Google Scholar 

  39. Civilibal, M. et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr. Nephrol. 21, 1426–1433 (2006).

    Article  Google Scholar 

  40. Amann, K., Breitbach, M., Ritz, E. & Mall, G. Myocyte/capillary mismatch in the heart of uremic patients. J. Am. Soc. Nephrol. 9, 1018–1022 (1998).

    CAS  PubMed  Google Scholar 

  41. Mall, G., Huther, W, Schneider, J., Lundin, P. & Ritz, E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol. Dial. Transplant. 5, 39–44 (1990).

    Article  CAS  Google Scholar 

  42. Bosch, A., Ulmer, H. E., Keller, H. E., Bonzel, K. E. & Scharer, K. Electrocardiographic monitoring in children with chronic renal failure. Pediatr. Nephrol. 4, 140–144 (1990).

    Article  CAS  Google Scholar 

  43. Kocak, G. et al. QT/corrected QT (QTc) intervals and QT/QTc dispersions in children with chronic renal failure. Int. J. Cardiol. 70, 63–67 (1999).

    Article  CAS  Google Scholar 

  44. Bakiler, A. R., Yavascan, O., Harputluoglu, N., Kara, O. D. & Aksu, N. Evaluation of aortic stiffness in children with chronic renal failure. Pediatr. Nephrol. 22, 1911–1919 (2007).

    Article  Google Scholar 

  45. Ulinski, T., Genty, J., Viau, C., Tillous-Borde, I. & Deschenes, G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr. Nephrol. 21, 1171–1178 (2006).

    Article  Google Scholar 

  46. Mitsnefes, M. M. et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr. Transplant. 5, 279–284 (2001).

    Article  CAS  Google Scholar 

  47. Mitsnefes, M. M. et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 65, 1461–1466 (2004).

    Article  Google Scholar 

  48. Mitsnefes, M. M. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J. Pediatr. 149, 671–675 (2006).

    Article  Google Scholar 

  49. Becker-Cohen, R. et al. Improved left ventricular mass index in children after renal transplantation. Pediatr. Nephrol. 23, 1545–1550 (2008).

    Article  Google Scholar 

  50. Gruppen, M. P. et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int. 63, 1058–1065 (2003).

    Article  Google Scholar 

  51. Matteucci, M. C. et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J. Am. Soc. Nephrol. 17, 218–226 (2006).

    Article  Google Scholar 

  52. Matteucci, M. C. et al. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 56, 1566–1570 (1999).

    Article  CAS  Google Scholar 

  53. Flynn, J. T. et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 52, 631–637 (2008).

    Article  CAS  Google Scholar 

  54. Bennett-Richards, K. J. et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62, 1372–1378 (2002).

    Article  CAS  Google Scholar 

  55. Bennett-Richards, K. et al. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105, 1810–1815 (2002).

    Article  CAS  Google Scholar 

  56. Briese, S., Claus, M. & Querfeld, U. Arterial stiffness in children after renal transplantation. Pediatr. Nephrol. 23, 2241–2245 (2008).

    Article  Google Scholar 

  57. Bilginer, Y. et al. Carotid intima–media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery. Pediatr. Transplant. 11, 888–894 (2007).

    Article  CAS  Google Scholar 

  58. Walsh, M., Culleton, B., Tonelli, M. & Manns, B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 67, 1500–1508 (2005).

    Article  Google Scholar 

  59. Fischbach, M. et al. Daily on-line haemodiafiltration: a pilot trial in children. Nephrol. Dial. Transplant. 19, 2360–2367 (2004).

    Article  Google Scholar 

  60. Muller, D. et al. Intensified hemodialysis regimens: neglected treatment options for children and adolescents. Pediatr. Nephrol. 23, 1729–1736 (2008).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc R. Lilien.

Ethics declarations

Competing interests

Marc R. Lilien's department has received an unrestricted research grant from Ferring Pharmaceuticals BV, The Netherlands.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lilien, M., Groothoff, J. Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 5, 229–235 (2009). https://doi.org/10.1038/nrneph.2009.10

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.10

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing